Abstract
Purpose of Review
The aim of this review is to evaluate the association of human papillomavirus and Chlamydia trachomatis coinfection with cervical intraepithelial lesions and cervical cancer.
Recent Findings
Sexually transmitted infections are admitted as one of the most common public health problems globally. Human papillomavirus (HPV) is the most frequent viral and Chlamydia trachomatis is the most frequent bacterial sexually transmitted infections. Infection with HPV is considered as necessary but not sufficient for cervical carcinogenesis. HPV infections are generally transient and asymptomatic, but persistence of HPV DNA in uterine cervix causes cervical cancer and precursor lesions such as low- and high-grade squamous intraepithelial lesions. Association between HPV and C. trachomatis coinfection was reported as a cofactor in cervical cancer development. Different researchers suggest a synergistic impact of HPV and C. trachomatis infections for all grades of cervical abnormalities. On the other hand, several reports found that C. trachomatis infection was not associated with HPV infections and abnormal cervical cytology.
Summary
Exact conclusions could not be made for the association between C. trachomatis and HPV coinfections in cervical carcinogenesis. Screening and treating C. trachomatis infections could decrease HPV persistence rates and improve disease control. Thus, it could decrease the risk of developing cervical intraepithelial lesions and malignancies.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.
Bodily J, Laimins LA. Persistence of human papillomavirus infection: keys to malignant progression. Trend Microbiol. 2011;19(1):33–9.
Kjaer SK, Frederiksen K, Munk C, Iftner T. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst. 2010;102:1478–88.
Choi YJ, Park JS. Clinical significance of human paillomavirus genotyping. J Gynecol Oncol. 2016;27:21.
Monsonego J, Cox JT, Behrens C, Sandri M, Franco EL, Yap PS, Huh W. Prevalence of high-risk human papillomavirus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: Data from the ATHENA trial. Gynecol Oncol. 2015;137:47–54.
Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Cho KR, et al. Cervical Cancer Version 2.2015. J Nat Compr Cancer Netw. 2015;13:395–404.
Shew ML, Fortenberry JD, Tu W, Juliar BE, Batteiger BE, Qadadri B, et al. Association of condom use, sexual behaviors, and sexually transmitted infections with the duration of genital human papillomavirus infection among adolescent women. Arch Pediatr Adolesc Med. 2006;160:151–6.
Plummer M, Peto J, Franceschi S. Time since first sexual intercourse and the risk of cervical cancer. Int J Canc. 2012;130(11):2638–44.
Discacciati MG, Gimenes F, Pennacchi PC, Faiao-Flores F, Zeferino LC, Derchain SM, et al. MMP-9/RECK imbalance: a mechanism asosociated with high-grade cervical lesions and genital infection by human papillomavirus and Chlamydia trachomatis. Cancer Epidemiol Biomarkers Prev. 2015;24:1539–47.
Lehtinen M, Ault KA, Lyytikainen E, Dillner J, Garland SM, Ferris DG, et al. Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia. Sex Transm Infect. 2011;87:372–6.
WHO Global health sector strategy on sexually transmitted infections 2016–2021. World Health Organization Department of Reproductive Health and Research. 2016.
Nonato DR, Alves RR, Ribeiro AA, Saddi VA, Segati KD, Almeida KP, et al. Prevalence and factors associated with coinfection of human papillomavirus and Chlamydia trachomatis in adolescents and young women. Am J Obstetr Gynecol. 2016;215(6):753–9.
Martel C, Plummer V, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664–70.
Guan P, Howell-Jones P, Li N, Bruni L, DeSanjose S, Franceschi S, et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131(10):2349–59.
Zur HH. Papillomaviruses in the causation of human cancers-a brief historical account. Virology. 2009;384:260–5.
Comar M, Monasta L, Seraceni S, Colli C, Luska V, Morassut S, et al. Chlamydia trachomatis and HPV coinfections in HIV negative men from a multi-ethnic area of Northern Italy at high prevalence of cervical malignancies. J Med Virol. 2017;89(9):1654–61.
Paavonen J. Chlamydia trachomatis infections of the female genital tract: state of the art. Ann Med. 2012;44:18–28.
Zhu H, Shen Z, Luo H, Zhang W, Zhu X. Chlamydia trachomatis infection-associated risk of cervical cancer. Medicine. 2016;95(13):3077.
Jensen KE, Thomsen LT, Schmiedel S, Frederiksen K, Norrild B, van den Brule A, et al. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study. Sex Transm Infect. 2014;90:550–5.
Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikaheimo I, et al. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA. 2001;285:47–51.
Tungsrithong N, Kasinpila C, Maneenin C, Namujju PB, Lehtinen M, Anttila A, et al. Lack of significant effects of Chlamydia trachomatis infection on cervical cancer risk in a nested case-control study in North-East Thailand. Asian Pac J Cancer Prev. 2014;15:1497–500.
•• Karim S, Souho T, Benlemlih M, Bennani B. Cervical cancer induction enhancement potential of Chlamydia trachomatis: a systematic review. Curr Microbiol. 2018;75:1667–74. In this recent review and meta analysis, it was found that Chlamydia trachomatis could be an independent predictor for cervical cancer.
• Yang X, Siddique A, Khan AA, Wang Q, Malik A, Jan AT, et al. Chlamydia trachomatis infection: their potential implication in the etiology of cervical cancer. J Canc. 2021;12(16):4891–900. In this study, women with Chlamydia trachomatis infections were reported to have an incresed risk for cervical cancer development.
Castle PE, Escoffery C, Schachter J, Rattray C, Schiffman M, Moncada J, et al. Chlamydia trachomatis, herpes simplex virus 2, and human T-cell lymphotrophic virus type 1 are not associated with grade of cervical neoplasia in Jamaican colposcopy patients. Sex Transm Dis. 2003;30:575–80.
Magalhaes PAF, Miranda CAN, Lima EG, Moizeis RNC, de Lima DBS, Cobucci RNO, et al. Genital tract infection with Chlamydia trachomatis in women attended at a cervical cancer screening program in Northeastern from Brasil. Arch Gynecol Obstet. 2015;291:1095–102.
Castellsague X, Pawlita M, Roura E, Margall N, Waterboer T, Bosch FX, et al. Prospective seroepidemiologic study on the role of human papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort. Int J Cancer. 2014;135:440–52.
Valadan M, Yarandi F, Eftekhar Z, Danvish S, Fathollahi MS, Mirsalehian A. Chlamydia trachomatis and cervical intraepithelial neoplasia in married women in a Middle Eastern community. East Mediterr Health J. 2010;16:304–7.
Koskela P, Anttila T, Bjorge T, Brunsvig A, Dillner J, Hakama M, et al. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer. 2000;85:35–9.
Smith JS, Bosetti C, Munoz N, Herrero R, Bosch FX, Eluf-Neto C, et al. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer. 2004;111:431–9.
Bhatla N, Puri K, Joseph E, Kriplani A, Iyer VK, Sreenivas V. Association of Chlamydia trachomatis infection with human papillomavirus (HPV) & cervical intraepithelial neoplasia- a pilot study. Indian J Med Res. 2013;137:533–9.
Chumduri C, Gurumurthy RK, Zadora PK, Mi Y, Meyer TF. Chlamydia infection promotes host DNA damage and proliferation but impairs the DNA damage response. Cell Host Microbe. 2013;13:746–58.
Kun D, Xiang-lin C, Ming Z, Qi L. Chlamydia inhibits host cell apoptosis by inducing Bag-1 via the MAPK/ERK survival pathway. Apoptosis. 2013;18:1083–92.
Silva J, Cerqueira F, Medeiros R. Chlamydia trachomatis infection: implications for HPV status and cervical cancer. Arch Gynecol Obstet. 2014;289:715–23.
Abreu A, Malaguti N, Souza RP, Uchimura NS, Ferreira EC, Pereira MW, et al. Association of human papillomavirus, Neisseria gonorrhoeae and Chlamydia trachomatis coinfections on the risk of high-grade squamous intraepithelial cervical lesion. Am J Cancer Res. 2016;6(6):1371–83.
Escarcega-Tame MA, Lopez-Hurtado M, Escobedo-Guerra MR, Reyes-Maldonado E, Castro-Escarpulli G, Guerra-Infante F. Co-infection between genotypes of the human papillomavirus and Chlamydia trachomatis in Mexican women. Int J STD AIDS. 2020;31(13):1255–62.
Ji Y, Ma XX, Li Z, Peppelenbosch MP, Ma Z, Pan Q. The burden of human papillomavirus and Chlamydia trachomatis coinfection in women: a large cohort study in Inner Mongolia. China J Infect Dis. 2019;219(2):206–14.
Khan AA, Abuderman A, Ashraf MT, Khan Z. Protein-protein interactions of HPV-Chlamydia trachomatis-human and their potential in cervical cancer. Future Microbiol. 2020;15:509–20.
Madaan N, Pandhi D, Sharma V, Bhattacharya SN, Guleria K, Mishra K, et al. Association of abnormal cervical cytology with coinfection of human papillomavirus and Chlamydia trachomatis. Indian J Sex Transm Dis AIDS. 2019;40(1):57–63.
Mancini F, Vescio F, Mochi S, Accardi L, Bonito P, Ciervo A. HPV and Chlamydia trachomatis coinfection in women with Pap smear abnomality: baseline data of the HPV Pathogen ISS study. Infez Med. 2018;26(2):139–44.
• Sangpichai S, Patarapadungkit N, Pientong C, Ekalaksananan T, Chaiwiriyakul S, Thongbor R, et al. Chlamydia tarchomatis infection in high-risk human papillomavirus based on cervical cytology specimen. Asian Pac J Cancer Prev. 2019;20(12):3843–7. This study demonstrated no association between human papillomavirus and Chlamydia trachomatis coinfections with cervical carcinogenesis and abnormal cervical cytology results.
Author information
Authors and Affiliations
Ethics declarations
Conflict of Interest
None.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Sexually Transmitted Disease
Rights and permissions
About this article
Cite this article
Kilic, C. Association of Human Papillomavirus and Chlamydia trachomatis Coinfection with Cervical Intraepithelial Lesions and Cervical Cancer. Curr Obstet Gynecol Rep 11, 44–47 (2022). https://doi.org/10.1007/s13669-021-00319-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13669-021-00319-y